| Exploring community pharmacists' views on generic medicines: a nationwide study from Malaysia. | |
| | |
MedLine Citation:
|
PMID: 21365404 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Objective To evaluate the Malaysian community pharmacists' views on generic medicines. Setting A sample of 1419 Malaysian community pharmacies with resident pharmacists. Method A cross-sectional nationwide survey using a self-completed mailing questionnaire. Main outcome measure Pharmacists' views on generic medicines including issues surrounding efficacy, safety, quality and bioequivalence. Results Responses were received from 219 pharmacies (response rate 15.4%). Only 50.2% of the surveyed pharmacists agreed that all products that are approved as generic equivalents can be considered therapeutically equivalent with the innovator medicines. Around 76% of respondents indicated that generic substitution of narrow therapeutic index medicines is inappropriate. The majority of the pharmacists understood that a generic medicine must contain the same amount of active ingredient (84.5%) and must be in the same dosage form as the innovator brand (71.7%). About 21% of respondents though that generic medicines are of inferior quality compared to innovator medicines. Most of the pharmacists (61.6%) disagreed that generic medicines produce more side-effects than innovator brand. Pharmacists graduated from Malaysian universities, twinning program and overseas universities were not differed significantly in their views on generic medicines. Additionally, the respondents appeared to have difficulty in ascertaining the bioequivalent status of the marketed generic products in Malaysia. Conclusion The Malaysian pharmacists' have lack of information and/or trust in the generic manufacturing and/or approval system in Malaysia. This issue should be addressed by pharmacy educators and relevant government agencies. |
| | |
Authors:
|
Chee Ping Chong; Mohamed Azmi Hassali; Mohd Baidi Bahari; Asrul Akmal Shafie |
Related Documents
:
|
21430304 - The coding masterpiece: a framework for the formal processes and pathways of health cla... 21548444 - Hypersensitivity reactions to blood components: document issued by the allergy committe... 22352634 - Vibrational spectroscopy: a tool being developed for the noninvasive monitoring of woun... 7383974 - A rapid method of isolation and fractionation of proteoglycans using a vertical tube ro... 10122864 - Quality leadership: the key to quality management. 12405894 - Clinicians' attitudes to clinical practice guidelines: a systematic review. |
Publication Detail:
|
Type: Journal Article Date: 2011-01-13 |
Journal Detail:
|
Title: International journal of clinical pharmacy Volume: 33 ISSN: 2210-7711 ISO Abbreviation: Int J Clin Pharm Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-03-02 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101554912 Medline TA: Int J Clin Pharm Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 124-31 Citation Subset: IM |
Affiliation:
|
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Minden, Penang, Malaysia, jjueping@gmail.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Coronary heart disease: health knowledge and behaviour.
Next Document: Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.